Know Cancer

or
forgot password

Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Kidney (Renal Cell) Cancer

Thank you

Trial Information

Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma


Inclusion Criteria:



1. Patients must be affected by HCC

2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)

3. Patients must be 18 years old or older

4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to
the TACE procedure.

5. Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

1. Subjects under the age of 18

2. Patients currently on dialysis

3. Pregnant women

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Proportion of patients that develop renal failure (defined as a decline of renal function, as measured by glomerular filtration rate, of 25% or more from pre-procedural)

Outcome Time Frame:

3 weeks

Safety Issue:

No

Principal Investigator

Nishita N. Kothary

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

HEP0035

NCT ID:

NCT01326390

Start Date:

May 2010

Completion Date:

September 2012

Related Keywords:

  • Kidney (Renal Cell) Cancer
  • Carcinoma
  • Carcinoma, Renal Cell
  • Carcinoma, Hepatocellular

Name

Location

Stanford University School of MedicineStanford, California  94305-5317